Diagnostic tests for the SARS-CoV-2 novel coronavirus must be widely available, and the barriers to testing must be low, if the world is to have an informed response to COVID-19. Being able to test in the midst of the current outbreak allows for targeted and proportionate preparation and response; testing will also be critical for monitoring of hotspots and future outbreaks.
Developing adequate testing capacity for the SARS-CoV-2 novel coronavirus will require taking advantage of the latest advances in scientific and technological innovation, and is contingent on cooperation between industry, governments and international organizations.
This project is exploring partnerships and collaborations that enable:
· Innovating testing strategies, including use of consumer connected devices and home testing
· Acceleration of laboratory testing in Africa as part of COVID-19 response on the continent
· Unlocking restrictions on supply chains of tests, materials, samples and personnel
· Understanding the implications of diverse regulatory approval pathways for tests
· Strategies for longer term monitoring or surveillance and addressing of SARS-CoV-2 hotspots